Vestor Capital
IBRX icon

Vestor Capital’s ImmunityBio IBRX Stock Holding History

Vestor Capital’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.1M Hold
44,835
– – 0.76% 38
2026
Q2 		$12.1M Buy
44,835
+33,299
+289% +$252K 0.76% 38
2026
Q1 		$88K Buy
+11,536
New +$79K 0.01% 205

Other funds holding IBRX

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
AH
Allen Holding New York $1.15B AUM 24.01% 1-Year Est. Return
Kercheville Advisors
Kercheville Advisors San Antonio, Texas $361M AUM 57.53% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
Sheets Smith Wealth Management
Sheets Smith Wealth Management Winston-Salem, North Carolina $958M AUM 21.88% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Plancorp LLC
Plancorp LLC Saint Louis, Missouri $4.4B AUM 16.7% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Vestor Capital's IBRX Position: Q3 2026 in Review

Vestor Capital held its ImmunityBio (IBRX) position steady in Q3 2026 at 44,835 shares worth $12.1M. The position accounts for 0.76% of the portfolio, ranked #38.

Vestor Capital first reported a position in IBRX in Q1 2026 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Vestor Capital held 44,835 shares of ImmunityBio worth $12.1M as of Q3 2026.
  • Vestor Capital left its ImmunityBio share count unchanged in Q3 2026.
  • ImmunityBio made up 0.76% of Vestor Capital's portfolio in Q3 2026, its #38 holding.
  • Vestor Capital first reported a position in ImmunityBio in Q1 2026 and has held it in 3 quarters since.
  • 147 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Vestor Capital's 13F filing for Q3 2026, filed 3 Nov 2026.